Benpen (benzylpenicillin Sodium) Injection Products To Be Discontinued

Summary Benpen (benzylpenicillin sodium) injection products are being discontinued in Australia, starting with the 600 mg strength on 30 November 2026. This is a Class III recall affecting all Australian distribution. The recall notice does not specify a safety reason for the discontinuation.

Reason
Progressive discontinuation of all products will start with the 600 mg strength from 30 November 2026.
Classification
Class III
Category
drug recall
Country
Australia
Agency
Therapeutic Goods Administration
Recall date
2026-05-27
Status
Ongoing
Distribution
Australia-wide

Official recall notice from Therapeutic Goods Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/6f81d3f6-79b1-42e8-8f96-64a332ea9f1b